Report Attribution: Chem Reports
The global Hirudin Market is witnessing a steady evolution as the medical community increasingly recognizes it as a superior alternative to traditional anticoagulants like heparin. Hirudin, a 65–66 amino acid peptide originally derived from the salivary glands of medicinal leeches (Hirudo medicinalis), is the most potent natural specific inhibitor of thrombin currently known.
Valued at USD 3,450 million in 2017, the market reached approximately USD 4,180 million by 2025. According to Chem Reports analysis, the market is projected to expand at a CAGR of 2.4% during the forecast period of 2025–2036. Growth is primarily driven by the rising prevalence of cardiovascular diseases and the shift toward recombinant biotechnology to overcome the supply constraints of natural extraction.
The following manufacturers represent the core competitive landscape of the global hirudin industry.
The Medicines Company (Novartis) – Global leader in thrombin-inhibitor research and specialized pharmaceuticals.
Abbott Laboratories – Major provider of cardiovascular diagnostic and treatment solutions.
Pfizer, Inc. – Focuses on integrated anticoagulant therapies and pharmaceutical development.
Teva Pharmaceutical Industries Ltd. – Key manufacturer of generic and specialized biochemical agents.
Minapharm Pharmaceuticals – Specialists in recombinant DNA technology and biopharmaceutical production.
Pentapharm (DSM Group) – Renowned for high-purity natural and synthetic peptides for diagnostic use.
Salubris Pharmaceuticals – A major force in the Chinese market for cardiovascular drug development.
Keyken – Japanese innovator in biochemical extraction and clinical applications.
Duoputai Pharmaceutical – Leading producer of proprietary hirudin-based traditional and modern medicines in China.
Natural Hirudin: Extracted directly from leeches. While highly potent, it faces supply limitations and higher production costs.
Recombinant Hirudin: Produced via genetic engineering (yeast or bacteria). This is the fastest-growing segment as it allows for mass production, consistent purity, and lower consumer pricing.
Thrombosis Disease: The primary application, including Deep Vein Thrombosis (DVT), cerebral embolism, and myocardial infarction.
Tumor Disease: Emerging research indicates hirudin inhibits thrombin-induced tumor cell proliferation and metastasis.
Cardiovascular Care: Prevention of blood stasis and activation of coagulation factors during surgery.
Others: Includes dermatology (skin stasis) and cosmetology.
North America: Currently the largest market by value due to high healthcare spending and advanced clinical research into recombinant peptides.
Europe: A mature market with established protocols for medicinal leech therapy and a strong presence of biochemical manufacturers like Pentapharm.
China: The most dynamic market. Hirudin is a staple in many proprietary Chinese medicines (e.g., blood capsules and oral liquids). Recombinant technology is being aggressively subsidized by the state.
Asia-Pacific (Japan/India): Fast-growing regions driven by an aging population and an increase in lifestyle-related chronic heart conditions.
Bargaining Power of Suppliers (Moderate): Supply of natural leeches is limited, but the shift to recombinant technology is reducing dependency on biological harvests.
Bargaining Power of Buyers (High): Hospitals and pharmaceutical firms demand high-purity standards and can choose between heparin-based or hirudin-based treatments.
Threat of New Entrants (Low): High barriers due to stringent FDA/EMA regulatory requirements and complex genetic engineering IP.
Threat of Substitutes (Moderate): Heparin remains a lower-cost substitute, though hirudin's lack of bleeding risks is a competitive advantage.
Competitive Rivalry (High): Intense competition between established Western pharma and rising Chinese biotechnology firms.
Strengths: Strongest natural thrombin inhibitor; independent of endogenous cofactors; low risk of bleeding compared to heparin.
Weaknesses: High cost of natural extraction; complex regulatory path for recombinant variants.
Opportunities: Genetic engineering to create hirudin-like peptides; potential applications in oncology; rising stroke rates in emerging economies.
Threats: Strict clinical trial requirements; volatility in traditional Chinese medicine raw material prices.
Biotech Shift: The transition from leech farming to Recombinant DNA technology is the defining trend of this decade.
Combination Therapy: Research into using hirudin alongside chemotherapy to inhibit thrombin-stimulated endothelial cell proliferation.
Proprietary Chinese Medicine (PCM): Integration of hirudin into mainstream pills and capsules in the Asian market for everyday cardiovascular maintenance.
Driver: The Stroke and Heart Attack Epidemic—Rising obesity and sedentary lifestyles are increasing the global demand for potent anticoagulants.
Driver: Heparin Limitations—Heparin often fails in patients with Antithrombin III deficiency; hirudin provides a life-saving alternative.
Challenge: Supply-Demand Gap—Demand for high-purity hirudin currently exceeds the global supply capacity.
Challenge: Regulatory hurdles—The approval process for new recombinant peptides is lengthy and capital-intensive.
Sourcing: Breeding of medicinal leeches or cultivation of recombinant yeast/bacteria strains.
Extraction/Synthesis: High-precision peptide synthesis and purification to 65-66 amino acid chains.
Formulation: Converting hirudin into injectable, oral, or topical forms.
Distribution: Global pharmaceutical logistics to specialized clinics and hospitals.
End-User: Clinical application in cardiovascular, orthopedic, and oncological surgery.
For Manufacturers: Invest in Recombinant Leech-like Peptides. The future of the market lies in synthetic scalability rather than biological extraction.
For Investors: Look toward China and Southeast Asia. The demand-supply gap is widest in these regions, offering significant room for new pharmaceutical entry.
For Healthcare Providers: Consider hirudin for patients with Heparin-Induced Thrombocytopenia (HIT), as it does not rely on the same cofactors.
End of Summary
For customized regional or country-level data, please contact Chem Reports.
Table of Contents
Global Hirudin Market Professional Survey Report
1 Industry Overview of Hirudin
1.1 Definition and Specifications of Hirudin
1.1.1 Definition of Hirudin
1.1.2 Specifications of Hirudin
1.2 Classification of Hirudin
1.2.1 Natural Hirudin
1.2.2 Recombinant Hirudin
1.3 Applications of Hirudin
1.3.1 Thrombosis Disease
1.3.2 Tumor Disease
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Hirudin
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hirudin
2.3 Manufacturing Process Analysis of Hirudin
2.4 Industry Chain Structure of Hirudin
3 Technical Data and Manufacturing Plants Analysis of Hirudin
3.1 Capacity and Commercial Production Date of Global Hirudin Major Manufacturers in
3.2 Manufacturing Plants Distribution of Global Hirudin Major Manufacturers in
3.3 R&D Status and Technology Source of Global Hirudin Major Manufacturers in
3.4 Raw Materials Sources Analysis of Global Hirudin Major Manufacturers in
4 Global Hirudin Overall Market Overview
4.1 -E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 -E Global Hirudin Capacity and Growth Rate Analysis
4.2.2 Hirudin Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 -E Global Hirudin Sales and Growth Rate Analysis
4.3.2 Hirudin Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 -E Global Hirudin Sales Price
4.4.2 Hirudin Sales Price Analysis (Company Segment)
5 Hirudin Regional Market Analysis
5.1 North America Hirudin Market Analysis
5.1.1 North America Hirudin Market Overview
5.1.2 North America -E Hirudin Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America -E Hirudin Sales Price Analysis
5.1.4 North America Hirudin Market Share Analysis
5.2 Europe Hirudin Market Analysis
5.2.1 Europe Hirudin Market Overview
5.2.2 Europe -E Hirudin Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe -E Hirudin Sales Price Analysis
5.2.4 Europe Hirudin Market Share Analysis
5.3 China Hirudin Market Analysis
5.3.1 China Hirudin Market Overview
5.3.2 China -E Hirudin Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China -E Hirudin Sales Price Analysis
5.3.4 China Hirudin Market Share Analysis
5.4 Japan Hirudin Market Analysis
5.4.1 Japan Hirudin Market Overview
5.4.2 Japan -E Hirudin Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan -E Hirudin Sales Price Analysis
5.4.4 Japan Hirudin Market Share Analysis
5.5 Southeast Asia Hirudin Market Analysis
5.5.1 Southeast Asia Hirudin Market Overview
5.5.2 Southeast Asia -E Hirudin Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia -E Hirudin Sales Price Analysis
5.5.4 Southeast Asia Hirudin Market Share Analysis
5.6 India Hirudin Market Analysis
5.6.1 India Hirudin Market Overview
5.6.2 India -E Hirudin Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India -E Hirudin Sales Price Analysis
5.6.4 India Hirudin Market Share Analysis
6 Global -E Hirudin Segment Market Analysis (by Type)
6.1 Global -E Hirudin Sales by Type
6.2 Different Types of Hirudin Product Interview Price Analysis
6.3 Different Types of Hirudin Product Driving Factors Analysis
6.3.1 Natural Hirudin Growth Driving Factor Analysis
6.3.2 Recombinant Hirudin Growth Driving Factor Analysis
7 Global -E Hirudin Segment Market Analysis (by Application)
7.1 Global -E Hirudin Consumption by Application
7.2 Different Application of Hirudin Product Interview Price Analysis
7.3 Different Application of Hirudin Product Driving Factors Analysis
7.3.1 Thrombosis Disease of Hirudin Growth Driving Factor Analysis
7.3.2 Tumor Disease of Hirudin Growth Driving Factor Analysis
7.3.3 Others of Hirudin Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Hirudin
8.1 The Medicines Company
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 The Medicines Company Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 The Medicines Company Hirudin Business Region Distribution Analysis
8.2 Keyken
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Keyken Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Keyken Hirudin Business Region Distribution Analysis
8.3 Minapharm
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Minapharm Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Minapharm Hirudin Business Region Distribution Analysis
8.4 Abbott
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Abbott Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Abbott Hirudin Business Region Distribution Analysis
8.5 SALUBRIS
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 SALUBRIS Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 SALUBRIS Hirudin Business Region Distribution Analysis
8.6 Pfizer, Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pfizer, Inc Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pfizer, Inc Hirudin Business Region Distribution Analysis
8.7 Teva Pharmaceutical Industries Ltd
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Teva Pharmaceutical Industries Ltd Hirudin Business Region Distribution Analysis
8.8 DUOPUTAI
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 DUOPUTAI Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 DUOPUTAI Hirudin Business Region Distribution Analysis
8.9 Pentapharm
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Pentapharm Hirudin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Pentapharm Hirudin Business Region Distribution Analysis
9 Development Trend of Analysis of Hirudin Market
9.1 Global Hirudin Market Trend Analysis
9.1.1 Global - Hirudin Market Size (Volume and Value) Forecast
9.1.2 Global - Hirudin Sales Price Forecast
9.2 Hirudin Regional Market Trend
9.2.1 North America - Hirudin Consumption Forecast
9.2.2 Europe - Hirudin Consumption Forecast
9.2.3 China - Hirudin Consumption Forecast
9.2.4 Japan - Hirudin Consumption Forecast
9.2.5 Southeast Asia - Hirudin Consumption Forecast
9.2.6 India - Hirudin Consumption Forecast
9.3 Hirudin Market Trend (Product Type)
9.4 Hirudin Market Trend (Application)
10 Hirudin Marketing Type Analysis
10.1 Hirudin Regional Marketing Type Analysis
10.2 Hirudin International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hirudin by Region
10.4 Hirudin Supply Chain Analysis
11 Consumers Analysis of Hirudin
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Hirudin Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Hirudin
Table Product Specifications of Hirudin
Table Classification of Hirudin
Figure Global Production Market Share of Hirudin by Type in
Figure Natural Hirudin Picture
Table Major Manufacturers of Natural Hirudin
Figure Recombinant Hirudin Picture
Table Major Manufacturers of Recombinant Hirudin
Table Applications of Hirudin
Figure Global Consumption Volume Market Share of Hirudin by Application in
Figure Thrombosis Disease Examples
Table Major Consumers in Thrombosis Disease
Figure Tumor Disease Examples
Table Major Consumers in Tumor Disease
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Hirudin by Regions
Figure North America Hirudin Market Size (Million USD) (-)
Figure Europe Hirudin Market Size (Million USD) (-)
Figure China Hirudin Market Size (Million USD) (-)
Figure Japan Hirudin Market Size (Million USD) (-)
Figure Southeast Asia Hirudin Market Size (Million USD) (-)
Figure India Hirudin Market Size (Million USD) (-)
Table Hirudin Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hirudin in
Figure Manufacturing Process Analysis of Hirudin
Figure Industry Chain Structure of Hirudin
Table Capacity and Commercial Production Date of Global Hirudin Major Manufacturers in
Table Manufacturing Plants Distribution of Global Hirudin Major Manufacturers in
Table R&D Status and Technology Source of Global Hirudin Major Manufacturers in
Table Raw Materials Sources Analysis of Global Hirudin Major Manufacturers in
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Hirudin -E
Figure Global -E Hirudin Market Size (Volume) and Growth Rate
Figure Global -E Hirudin Market Size (Value) and Growth Rate
Table -E Global Hirudin Capacity and Growth Rate
Table Global Hirudin Capacity (MT) List (Company Segment)
Table -E Global Hirudin Sales (MT) and Growth Rate
Table Global Hirudin Sales (MT) List (Company Segment)
Table -E Global Hirudin Sales Price (USD/Kg)
Table Global Hirudin Sales Price (USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Hirudin -E
Figure North America -E Hirudin Sales Price (USD/Kg)
Figure North America Hirudin Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Hirudin -E
Figure Europe -E Hirudin Sales Price (USD/Kg)
Figure Europe Hirudin Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Hirudin -E
Figure China -E Hirudin Sales Price (USD/Kg)
Figure China Hirudin Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Hirudin -E
Figure Japan -E Hirudin Sales Price (USD/Kg)
Figure Japan Hirudin Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Hirudin -E
Figure Southeast Asia -E Hirudin Sales Price (USD/Kg)
Figure Southeast Asia Hirudin Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Hirudin -E
Figure India -E Hirudin Sales Price (USD/Kg)
Figure India Hirudin Sales Market Share
Table Global -E Hirudin Sales (MT) by Type
Table Different Types Hirudin Product Interview Price
Table Global -E Hirudin Sales (MT) by Application
Table Different Application Hirudin Product Interview Price
Table The Medicines Company Information List
Table Product Overview
Table The Medicines Company Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure The Medicines Company Hirudin Business Region Distribution
Table Keyken Information List
Table Product Overview
Table Keyken Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Keyken Hirudin Business Region Distribution
Table Minapharm Information List
Table Product Overview
Table Minapharm Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Minapharm Hirudin Business Region Distribution
Table Abbott Information List
Table Product Overview
Table Abbott Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Abbott Hirudin Business Region Distribution
Table SALUBRIS Information List
Table Product Overview
Table SALUBRIS Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure SALUBRIS Hirudin Business Region Distribution
Table Pfizer, Inc Information List
Table Product Overview
Table Pfizer, Inc Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Pfizer, Inc Hirudin Business Region Distribution
Table Teva Pharmaceutical Industries Ltd Information List
Table Product Overview
Table Teva Pharmaceutical Industries Ltd Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Teva Pharmaceutical Industries Ltd Hirudin Business Region Distribution
Table DUOPUTAI Information List
Table Product Overview
Table DUOPUTAI Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure DUOPUTAI Hirudin Business Region Distribution
Table Pentapharm Information List
Table Product Overview
Table Pentapharm Hirudin Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Pentapharm Hirudin Business Region Distribution
Figure Global - Hirudin Market Size (MT) and Growth Rate Forecast
Figure Global - Hirudin Market Size (Million USD) and Growth Rate Forecast
Figure Global - Hirudin Sales Price (USD/Kg) Forecast
Figure North America - Hirudin Consumption Volume (MT) and Growth Rate Forecast
Figure China - Hirudin Consumption Volume (MT) and Growth Rate Forecast
Figure Europe - Hirudin Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia - Hirudin Consumption Volume (MT) and Growth Rate Forecast
Figure Japan - Hirudin Consumption Volume (MT) and Growth Rate Forecast
Figure India - Hirudin Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Hirudin by Type -
Table Global Consumption Volume (MT) of Hirudin by Application -
Table Traders or Distributors with Contact Information of Hirudin by Region
The following manufacturers represent the core competitive landscape of the global hirudin industry.
The Medicines Company (Novartis) – Global leader in thrombin-inhibitor research and specialized pharmaceuticals.
Abbott Laboratories – Major provider of cardiovascular diagnostic and treatment solutions.
Pfizer, Inc. – Focuses on integrated anticoagulant therapies and pharmaceutical development.
Teva Pharmaceutical Industries Ltd. – Key manufacturer of generic and specialized biochemical agents.
Minapharm Pharmaceuticals – Specialists in recombinant DNA technology and biopharmaceutical production.
Pentapharm (DSM Group) – Renowned for high-purity natural and synthetic peptides for diagnostic use.
Salubris Pharmaceuticals – A major force in the Chinese market for cardiovascular drug development.
Keyken – Japanese innovator in biochemical extraction and clinical applications.
Duoputai Pharmaceutical – Leading producer of proprietary hirudin-based traditional and modern medicines in China.
Natural Hirudin: Extracted directly from leeches. While highly potent, it faces supply limitations and higher production costs.
Recombinant Hirudin: Produced via genetic engineering (yeast or bacteria). This is the fastest-growing segment as it allows for mass production, consistent purity, and lower consumer pricing.
Thrombosis Disease: The primary application, including Deep Vein Thrombosis (DVT), cerebral embolism, and myocardial infarction.
Tumor Disease: Emerging research indicates hirudin inhibits thrombin-induced tumor cell proliferation and metastasis.
Cardiovascular Care: Prevention of blood stasis and activation of coagulation factors during surgery.
Others: Includes dermatology (skin stasis) and cosmetology.
Upto 24 to 48 hrs (Working Hours)
Upto 72 hrs max (Working Hours) - Weekends and Public Holidays
Single User License - Allows access to only one person to the report.
Multi User License - Allows sharing with max 5 persons within organization.
Corporate License – Can be shared across entire organization.
Online Payments with PayPal
Wire Transfer / Bank Transfer
At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.
ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.
We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.
Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.
Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.